First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac

The treatment of oligometastatic disease using MR guidance is an evolving field. Since August 2018 patients are treated on a 1.5 Tesla MR-Linac (MRL). We present current workflows and practice standards from seven institutions for the initial patients treated for lymph node and liver metastases.

Detalles Bibliográficos
Autores principales: Janssen, Tomas M., Aitken, Katharine, Alongi, Filippo, Barry, Aisling, Bernchou, Uffe, Boeke, Simon, Hall, William A., Hosni, Ali, Kroon, Petra.S., Nachbar, Marcel, Saeed, Hina, Jürgenliemk-Schulz, Ina M., Schytte, Tine, Verkooijen, Helena M., Nowee, Marlies.E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Short communications and technical note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108982/
https://www.ncbi.nlm.nih.gov/pubmed/35586786
http://dx.doi.org/10.1016/j.tipsro.2022.04.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108982/
https://www.ncbi.nlm.nih.gov/pubmed/35586786
http://dx.doi.org/10.1016/j.tipsro.2022.04.005

Ejemplares similares